Colonization of pregnant women and their newborn infants with group-B streptococci

A A Kulkarni1, S G Pawar, C A Dharmadhikari

  • 1Department of Microbiology, Government Medical College, Miraj - 416 410, Maharashtra, India.

Insights

Group B Streptococcus (GBS) colonization is low in pregnant women (2.52%) and neonates (1.26%). Neonates did not develop GBS sepsis, and Selective Broth Medium proved superior for sample transport.

Area of Science:

  • Microbiology
  • Neonatal Health
  • Infectious Diseases

Background:

  • Group B Streptococcus (GBS) is a significant cause of neonatal infections like meningitis and septicaemia.
  • GBS prevalence varies geographically, necessitating local epidemiological data.
  • Understanding GBS colonization in pregnant women and newborns is crucial for infection prevention.

Purpose of the Study:

  • To determine the prevalence of GBS colonization in pregnant women and their neonates.
  • To identify colonization sites in neonates.
  • To evaluate the efficacy of different transport media for GBS detection.

Main Methods:

  • A prospective study involving 317 pregnant women and their neonates from June 1998 to April 1999.
  • Swabs collected from pregnant women and neonates (throat, ears, nares, umbilicus).
  • Comparison of Selective Broth Medium (SBM) with Stuart transport medium and filter paper for GBS detection.

Main Results:

  • GBS colonization rates were 2.52% in pregnant women and 1.26% in neonates.
  • Neonates showed colonization at multiple sites (throat, ears, nares) shortly after birth and before discharge.
  • Selective Broth Medium (SBM) demonstrated superior performance compared to other transport methods.
  • All GBS isolates were sensitive to Ampicillin, Erythromycin, and Penicillin; resistance was high for Gentamicin, Tetracycline, and Kanamycin.

Conclusions:

  • GBS colonization rates in this cohort were relatively low, and no neonatal sepsis cases were observed.
  • Selective Broth Medium (SBM) is an effective method for transporting GBS samples.
  • Antibiotic susceptibility patterns indicate sensitivity to penicillin-group antibiotics and resistance to others, informing treatment strategies.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...